latanoprost + D930

Latanoprost + D930 is a combination drug presumed to contain **latanoprost** and an agent designated as D930. Latanoprost is a **prostaglandin F2-alpha analog** that lowers intraocular pressure (IOP) primarily by increasing uveoscleral outflow. It is widely used in the treatment of open-angle glaucoma and ocular hypertension. The exact nature, mechanism of action, and clinical data for D930 are not available in the provided search results or known medical databases. Latanoprost's mechanism and indications are well-defined, while D930 remains unidentified; thus, the description focuses on latanoprost's established properties as a topical small molecule for ocular pressure reduction[1][3][4].